| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Revenue | $0.2B | $0.2B | $0.3B | $0.3B | $0.2B |
| Cost of Revenue | — | — | — | — | — |
| Gross Profit | — | — | — | — | — |
| R&D Expense | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — |
| Operating Income | — | — | — | — | — |
| Net Income | $-0.5B | $-0.2B | $0.0B | $0.1B | $0.2B |
| EPS (Basic) | $-3.49 | $-1.60 | $0.02 | $0.79 | $1.27 |
| EPS (Diluted) | $-3.49 | $-1.60 | $0.02 | $0.79 | $1.27 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Total Assets | $4.7B | $7.0B | $8.1B | $8.2B | $7.5B |
| Current Assets | — | — | — | — | — |
| Cash & Equivalents | $0.2B | $0.1B | $0.2B | $0.3B | $0.3B |
| Total Liabilities | $3.2B | $5.0B | $5.8B | $5.8B | $4.9B |
| Current Liabilities | — | — | — | — | — |
| Stockholders' Equity | — | — | — | $2.5B | $2.6B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ |
|---|---|---|---|---|---|
| Operating Cash Flow | $-0.0B | $0.1B | $0.1B | $0.1B | $0.2B |
| Investing Cash Flow | $1.9B | $0.8B | $-0.0B | $-0.8B | $-0.4B |
| Capital Expenditures | — | — | — | — | — |
| Financing Cash Flow | $-1.8B | $-0.9B | $-0.2B | $0.7B | $0.1B |